These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 30221531)

  • 1. Epidemiology of Head and Neck Cancers in Northern Iran: A 10-Year Trend Study From Golestan Province.
    Taziki MH; Fazel A; Salamat F; Sedaghat SM; Ashaari M; Poustchi H; Shakeri R; Hoseinpoor R; Hasanpour-Heidari S; Roshandel G
    Arch Iran Med; 2018 Sep; 21(9):406-411. PubMed ID: 30221531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Descriptive Epidemiology of Lymphoma in Northern Iran: Results from the Golestan Registry 2004-2013.
    Jafari-Delouei N; Naeimi-Tabiei M; Fazel A; Ashaari M; Hatami E; Sedaghat SM; Poorabbasi M; Hasanpour-Heidari S; Ghasemi-Kebria F; Salamat F; Moghaddami A; Gholami M; Bray F; Roshandel G
    Arch Iran Med; 2020 Mar; 23(3):150-154. PubMed ID: 32126782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in the Incidence of Stomach Cancer in Golestan Province, a High-risk Area in Northern Iran, 2004-2016.
    Ghasemi-Kebria F; Amiriani T; Fazel A; Naimi-Tabiei M; Norouzi A; Khoshnia M; Seyyedmajidi M; Pooshani A; Mousaviemadi S; Poorkhani H; Sedaghat S; Salamat F; Hasanpour-Heidari S; Jafari-Delouie N; Gholami M; Semnani S; Roshandel G; Weiderpass E; Malekzadeh R
    Arch Iran Med; 2020 Jun; 23(6):362-368. PubMed ID: 32536172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Building cancer registries in a lower resource setting: The 10-year experience of Golestan, Northern Iran.
    Roshandel G; Semnani S; Fazel A; Honarvar M; Taziki M; Sedaghat S; Abdolahi N; Ashaari M; Poorabbasi M; Hasanpour S; Hosseini S; Mansuri S; Jahangirrad A; Besharat S; Moghaddami A; Mirkarimi H; Salamat F; Ghasemi-Kebria F; Jafari N; Shokoohifar N; Gholami M; Sadjadi A; Poustchi H; Bray F; Malekzadeh R
    Cancer Epidemiol; 2018 Feb; 52():128-133. PubMed ID: 29306787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal and Geographical Trends of Incidence of Thyroid Cancer in Golestan, Iran, 2004-2013.
    Salamat F; Aryannia A; Rajaei S; Naeimi-Tabiei M; Afghani R; Sedaghat SM; Naeimi-Tabiei E; Salamat F; Hosseinpour R; Fazel A; Araghi M; Roshandel G
    Arch Iran Med; 2021 Jan; 24(1):1-6. PubMed ID: 33588561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and Temporal Variations of Bone and Soft Tissue Cancers in the Golestan Province, Northern Iran, 2004-2016.
    Soghi A; Aarabi M; Sedaghat SM; Salamat F; Ghasemi-Kebria F; Roshandel G; Abdolahi N
    Arch Iran Med; 2023 Feb; 26(2):62-68. PubMed ID: 37543925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary Biliary Tract Cancers in Golestan, Iran: 13-Year Experience of Golestan Population-Based Cancer Registry.
    Ashkbari A; Isapanah Amlashi F; Besharat S; Mofidi M; Amiriani T; Fazel A; Alimadadi M; Salamat F; Sedaghat SM; Livani S; Bagheri A; Semnani S; Norouzi A; Roshandel G
    Arch Iran Med; 2023 Sep; 26(9):504-509. PubMed ID: 38310406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence Rates and Time Trends of Skin Cancer in Golestan Province, Northeastern Iran, 2005-2018.
    Mehri M; Karazhian M; Nikyar A; Mehri R; Bagheri A; Akbari M; Roshandel G; Teimoorian M
    Arch Iran Med; 2024 Jun; 27(6):289-297. PubMed ID: 38855798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Five-year relative survival and determinants of excess mortality in patients with head and neck and thyroid cancers: A population-based study from Golestan province, Northern Iran.
    Taziki M; Rajaei S; Firouzei G; Hashemzadeh F; Rajabalian M; Mansoury M; Sedaghat S; Ghahraman F; Ghasemi-Kebria F; Weiderpass E; Roshandel G
    Cancer Epidemiol; 2022 Oct; 80():102247. PubMed ID: 36081275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporal and geographical variations in colorectal cancer incidence in Northern Iran 2004-2013.
    Hasanpour-Heidari S; Fazel A; Semnani S; Khandoozi SR; Amiriani T; Sedaghat S; Hosseinpoor R; Azarhoush R; Poorabbasi M; Naeimi-Tabiei M; Roshandel G; Bray F; Weiderpass E
    Cancer Epidemiol; 2019 Apr; 59():143-147. PubMed ID: 30771699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Esophageal and gastric cancer incidence trends in Golestan, Iran: An age-period-cohort analysis 2004 to 2018.
    Ghasemi-Kebria F; Semnani S; Fazel A; Etemadi A; Amiriani T; Naeimi-Tabiei M; Hasanpour-Heidari S; Salamat F; Jafari-Delouie N; Sedaghat S; Sadeghzadeh H; Akbari M; Mehrjerdian M; Weiderpass E; Roshandel G; Bray F; Malekzadeh R
    Int J Cancer; 2023 Jul; 153(1):73-82. PubMed ID: 36943026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of childhood cancers in golestan province of iran.
    Moradi A; Semnani S; Roshandel G; Mirbehbehani N; Keshtkar A; Aarabi M; Moghaddami A; Cheraghali F
    Iran J Pediatr; 2010 Sep; 20(3):335-42. PubMed ID: 23056726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colorectal cancer incidence trends in Golestan, Iran: An age-period-cohort analysis 2004-2018.
    Ghasemi-Kebria F; Jafari-Delouie N; Semnani S; Fazel A; Etemadi A; Norouzi A; Khandoozi R; Besharat S; Shokouhifar N; Mirkarimi H; Sedaghat S; Mansoury M; Mehrjerdian M; Weiderpass E; Roshandel G; Bray F; Malekzadeh R
    Cancer Epidemiol; 2023 Oct; 86():102415. PubMed ID: 37442047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer incidence trends in Golestan, Iran: An age-period-cohort analysis by ethnic region, 2004-2018.
    Ghasemi-Kebria F; Fazel A; Semnani S; Etemadi A; Naeimi-Tabiei M; Hasanpour-Heidari S; Salamat F; Jafari-Delouie N; Sedaghat S; Sadeghzadeh H; Akbari M; Mehrjerdian M; Weiderpass E; Roshandel G; Bray F; Malekzadeh R
    Cancer Epidemiol; 2024 Apr; 89():102525. PubMed ID: 38228040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Second esophageal neoplasms after head and neck index tumor: Incidence, risk factors and prognosis.
    Pujol A; Llansana A; Pérez-Ugarte L; Sauter B; Quer M; León X
    Acta Otorrinolaringol Esp (Engl Ed); 2023; 74(6):339-345. PubMed ID: 37149128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A nationwide study on cancer recurrences, second primary tumours, distant metastases and survival after treatment for primary head and neck cancer in the Netherlands.
    van de Weerd C; van Dijk BAC; Merkx MAW; Takes RP; Brands MT
    Eur J Surg Oncol; 2023 Jul; 49(7):1154-1161. PubMed ID: 36964057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of Malignant Brain and Central Nervous System Tumors in Golestan, Iran, 2004-2013.
    Araghi M; Roshandel G; Hasanpour-Heidari S; Fazel A; Sedaghat SM; Pourkhani A; Kazeminejhad V; Miranda-Filho A; Bray F; Arnold M
    Arch Iran Med; 2020 Jan; 23(1):1-6. PubMed ID: 31910628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population-based cancer survival in the Golestan province in the northeastern part of Iran 2007-2012.
    Nemati S; Saeedi E; Roshandel G; Nahvijou A; Badakhshan A; Akbari M; Sedaghat SM; Hasanpour-Heidari S; Hosseinpour R; Salamat F; Lotfi F; Khosravi A; Soerjomataram I; Bray F; Zendehdel K
    Cancer Epidemiol; 2022 Apr; 77():102089. PubMed ID: 35042146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of cervical cancer in Iran in 2016: A nationwide study of incidence and regional variation.
    Anjam Majoumerd A; Hosseini S; Hosseini SMH; Roshandel G; Rahmanian V; Hazar N
    Cancer Rep (Hoboken); 2024 Feb; 7(2):e1973. PubMed ID: 38214217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colorectal Cancer Incidence in Iran Based on Sex, Age, and Geographical Regions: A Study of 2014-2017 and Projected Rates to 2025.
    AziziKia H; Teymourzadeh A; Kouchaki H; Nakhostin-Ansari A; Jafari Doudaran P; Ahmadinejad I; Hoveidaei A; Roshandel G
    Arch Iran Med; 2024 Apr; 27(4):174-182. PubMed ID: 38685843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.